Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site.

Miyata T, Iwanaga S, Sakata Y, Aoki N.

Proc Natl Acad Sci U S A. 1982 Oct;79(20):6132-6.

2.
3.

Coagulation factor XII (Hageman factor) Washington D.C.: inactive factor XIIa results from Cys-571----Ser substitution.

Miyata T, Kawabata S, Iwanaga S, Takahashi I, Alving B, Saito H.

Proc Natl Acad Sci U S A. 1989 Nov;86(21):8319-22.

4.
5.

Structure-function relationships in staphylokinase as revealed by "clustered charge to alanine" mutagenesis.

Silence K, Hartmann M, Gührs KH, Gase A, Schlott B, Collen D, Lijnen HR.

J Biol Chem. 1995 Nov 10;270(45):27192-8.

6.

Identification of the plasminogen-binding site of human alpha 2-plasmin inhibitor.

Sasaki T, Morita T, Iwanaga S.

J Biochem. 1986 Jun;99(6):1699-705.

7.

Structure-function analysis of the reactive site in the first Kunitz-type domain of human tissue factor pathway inhibitor-2.

Chand HS, Schmidt AE, Bajaj SP, Kisiel W.

J Biol Chem. 2004 Apr 23;279(17):17500-7. Epub 2004 Feb 16. Erratum in: J Biol Chem. 2004 Jun 4;279(23):24906.

8.
9.
10.

Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate.

Lind SE, McDonagh JR, Smith CJ.

Blood. 1993 Sep 1;82(5):1522-31.

11.

NH2-terminal structural motifs in staphylokinase required for plasminogen activation.

Schlott B, Gührs KH, Hartmann M, Röcker A, Collen D.

J Biol Chem. 1998 Aug 28;273(35):22346-50.

12.
14.

Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive-site loop.

Audenaert AM, Knockaert I, Collen D, Declerck PJ.

J Biol Chem. 1994 Jul 29;269(30):19559-64.

15.

Identification of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae.

Bergmann S, Wild D, Diekmann O, Frank R, Bracht D, Chhatwal GS, Hammerschmidt S.

Mol Microbiol. 2003 Jul;49(2):411-23.

16.

Structural studies of the interactions of normal and abnormal human plasmins with bovine basic pancreatic trypsin inhibitor.

Takeda-Shitaka M, Kamiya K, Miyata T, Ohkura N, Madoiwa S, Sakata Y, Umeyama H.

Chem Pharm Bull (Tokyo). 1999 Mar;47(3):322-8.

PMID:
10212382
17.

Amino acid sequence of the active site of human pseudocholinesterase.

Yamato K, Huang IY, Muensch H, Yoshida A, Goedde HW, Agarwal DP.

Biochem Genet. 1983 Feb;21(1-2):135-45.

PMID:
6838485
18.

Different sites of acivicin binding and inactivation of gamma-glutamyl transpeptidases.

Smith TK, Ikeda Y, Fujii J, Taniguchi N, Meister A.

Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2360-4.

19.

Supplemental Content

Support Center